Halozyme Therapeutics
HALO
#2450
Rank
A$10.55 B
Marketcap
A$89.10
Share price
1.60%
Change (1 day)
-6.05%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): A$0.72 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$1.39 Billion. a decrease over its 2024 earnings that were of A$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 A$0.64 B-16.2%
2024 A$0.77 B59.94%
2023 A$0.48 B39.94%
2022 A$0.34 B0.16%
2021 A$0.34 B92.2%
2020 A$0.17 B-278.96%
2019 -A$0.11 Billion-9.45%
2018 -A$0.12 Billion-229.51%
2017 A$85.68 M-160.48%
2016 -A$0.15 Billion216.03%
2015 -A$44.83 Million-52.86%
2014 -A$95.09 Million-18.09%
2013 -A$0.12 Billion55.88%
2012 -A$74.48 Million169.94%
2011 -A$27.6 Million-63.44%
2010 -A$75.46 Million-7.19%
2009 -A$81.3 Million15.91%
2008 -A$70.14 Million83.89%
2007 -A$38.15 Million78.1%
2006 -A$21.42 Million16%
2005 -A$18.47 Million45.24%
2004 -A$12.72 Million682.42%
2003 -A$1.63 Million1659.12%
2002 -A$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.66 B 7,086.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.17 B 2,083.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$35.78 B 5,411.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.70 B 1,549.11%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-A$0.71 Billion-208.17%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$42.8 M-93.41%๐Ÿ‡บ๐Ÿ‡ธ USA